p3 health partners inc - PIII

PIII

Close Chg Chg %
8.42 -0.06 -0.70%

Open Market

8.36

-0.06 (0.70%)

Volume: 2.85K

Last Updated:

Sep 10, 2026, 10:54 AM EDT

Company Overview: p3 health partners inc - PIII

PIII Key Data

Open

$8.50

Day Range

8.36 - 8.54

52 Week Range

1.52 - 16.89

Market Cap

$35.13M

Shares Outstanding

3.91M

Public Float

1.57M

Beta

1.62

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$32.94

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

63.58K

 

PIII Performance

1 Week
 
-3.96%
 
1 Month
 
-22.45%
 
3 Months
 
-26.57%
 
1 Year
 
4.42%
 
5 Years
 
-98.18%
 

PIII Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About p3 health partners inc - PIII

P3 Health Partners, Inc. is a population health care management company, which engages in the provision of professional support services to doctors and clinicians. The firm offers capital care model, data and technology, physician leadership, and community outreach tools to create patient outcomes and experiences. The company was founded by Sherif Abdou and Amir Bacchus on August 20, 2020 and is headquartered in Henderson, NV.

PIII At a Glance

P3 Health Partners, Inc.
2370 Corporate Circle
Henderson, Nevada 89074
Phone 1-702-872-3851 Revenue 1.46B
Industry Miscellaneous Commercial Services Net Income -147,948,000.00
Sector Commercial Services Employees 320
Fiscal Year-end 12 / 2026
View SEC Filings

PIII Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.008
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -1.547
Enterprise Value to Sales 0.197
Total Debt to Enterprise Value 0.998

PIII Efficiency

Revenue/Employee 4,559,625.00
Income Per Employee -462,337.50
Receivables Turnover 15.225
Total Asset Turnover 2.026

PIII Liquidity

Current Ratio 0.244
Quick Ratio 0.244
Cash Ratio 0.047

PIII Profitability

Gross Margin -9.891
Operating Margin -18.525
Pretax Margin -22.004
Net Margin -10.14
Return on Assets -20.544
Return on Equity N/A
Return on Total Capital -112.037
Return on Invested Capital -113.06

PIII Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 217.553
Total Debt to Total Assets 43.734
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 181.631
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for P3 Health Partners Inc - PIII

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.05B 1.27B 1.50B 1.46B
Sales Growth
+64.66% +20.67% +18.48% -2.76%
Cost of Goods Sold (COGS) incl D&A
1.14B 1.32B 1.65B 1.60B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
87.29M 86.67M 86.06M 84.16M
Depreciation
2.49M 2.38M 2.36M 2.20M
Amortization of Intangibles
84.80M 84.30M 83.70M 81.96M
COGS Growth
+71.32% +15.46% +24.52% -2.55%
Gross Income
(95.04M) (55.04M) (144.97M) (144.32M)
Gross Income Growth
-209.57% +42.09% -163.40% +0.45%
Gross Profit Margin
-9.06% -4.35% -9.66% -9.89%
2022 2023 2024 2025 5-year trend
SG&A Expense
162.38M 125.53M 113.93M 107.23M
Research & Development
- - - -
-
Other SG&A
162.38M 125.53M 113.93M 107.23M
SGA Growth
+3.27% -22.70% -9.24% -5.88%
Other Operating Expense
(11.46M) (12.71M) 53.70M 18.75M
Unusual Expense
1.31B (363.00K) (14.06M) (7.85M)
EBIT after Unusual Expense
(1.55B) (167.50M) (298.54M) (262.45M)
Non Operating Income/Expense
2.76M (249.00K) 14.73M (3.58M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
11.40M 15.98M 22.17M 55.03M
Interest Expense Growth
+3.68% +40.17% +38.71% +148.20%
Gross Interest Expense
11.40M 15.98M 22.17M 55.03M
Interest Capitalized
- - - -
-
Pretax Income
(1.56B) (183.73M) (305.99M) (321.06M)
Pretax Income Growth
-663.29% +88.22% -66.54% -4.92%
Pretax Margin
-148.62% -14.51% -20.39% -22.00%
Income Tax
1.86M 2.69M 4.39M 2.02M
Income Tax - Current - Domestic
1.86M 2.69M 5.48M 3.52M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - (1.09M) (1.50M)
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(1.56B) (186.43M) (310.38M) (323.09M)
Minority Interest Expense
(1.29B) (128.65M) (174.53M) (175.14M)
Net Income
(270.13M) (57.77M) (135.85M) (147.95M)
Net Income Growth
-72.63% +78.61% -135.14% -8.91%
Net Margin Growth
-25.74% -4.56% -9.05% -10.14%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(270.13M) (57.77M) (135.85M) (147.95M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(270.13M) (57.77M) (135.85M) (147.95M)
EPS (Basic)
-324.836 -30.4425 -46.788 -45.2579
EPS (Basic) Growth
-72.63% +90.63% -53.69% +3.27%
Basic Shares Outstanding
831.58K 1.90M 2.90M 3.27M
EPS (Diluted)
-324.836 -30.4425 -54.0575 -45.2579
EPS (Diluted) Growth
-72.63% +90.63% -77.57% +16.28%
Diluted Shares Outstanding
831.58K 1.90M 2.94M 3.27M
EBITDA
(158.67M) (81.19M) (226.54M) (186.14M)
EBITDA Growth
+11.47% +48.83% -179.04% +17.84%
EBITDA Margin
-15.12% -6.41% -15.10% -12.76%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 18.50
Number of Ratings 2 Current Quarters Estimate -3.965
FY Report Date 09 / 2026 Current Year's Estimate -7.27
Last Quarter’s Earnings -0.63 Median PE on CY Estimate N/A
Year Ago Earnings -45.26 Next Fiscal Year Estimate -10.165
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 2 2
Mean Estimate -3.97 -5.62 -7.27 -10.17
High Estimates -0.53 -4.20 0.30 -6.45
Low Estimate -7.40 -7.04 -14.84 -13.88
Coefficient of Variance -122.52 -35.73 -147.26 -51.69

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

P3 Health Partners Inc in the News